Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2022 09:00 ET | Source: Kaplan Fox & Kilsheimer LLP

Y-mAbs Therapeutics, Inc. Shareholder Alert: Kaplan Fox Investigates Potential Securities Fraud

NEW YORK, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the...
October 31, 2022 10:13 ET | Source: Kaplan Fox & Kilsheimer LLP

Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) Investor Alert: Kaplan Fox Investigates Potential Securities Fraud

NEW YORK, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the...